HELICOS BIO (NASDAQ:HLCS)
1.59
0.09 (5.36%)
| HELICOS BIO (NASDAQ:HLCS) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $1.68 | 52 Week High | $3.54 | ||
| Open | $1.59 | 52 Week Low | $0.21 | ||
| Day High | $1.65 | P/E | N/A | ||
| Day Low | $1.40 | EPS | $-0.71 | ||
| Volume | 1,496,641 | ||||
| More HLCS Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| AIG | 4 | OSIR | 3 |
| PGI | 2 | OPXA | 2 |
| ANPI | 2 | SVA | 2 |
| HOV | 2 | ORH | 2 |
| ATCO | 2 | ATHR | 2 |
| CLWR | 2 | SPPI | 2 |
Entities who have mentioned HLCS
- Thomas Weisel Partners Group | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Credit Suisse | View Related Stories »
- S3 | View Related Stories »
- Highland Capital | View Related Stories »
- Banc of America | View Related Stories »
- William Blair | View Related Stories »
- KeyBanc | View Related Stories »
- UBS | View Related Stories »
- JPMorgan | View Related Stories »
- Morgan Keegan & Company | View Related Stories »
- 13D | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Morgan Joseph | View Related Stories »
- Robert W Baird | View Related Stories »
- Northland Securities | View Related Stories »
- Bakken Formation | View Related Stories »
- Barclays | View Related Stories »
- Bankruptcy | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Stifel Nicolaus | View Related Stories »
- Vanguard | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- After-Hours Movers | View Related Stories »
View All ReportsStreetInsider.com Reports on HLCS
- Helicos BioSciences (HLCS) Sells Genetic Analysis System to Dutch Research Collaborative
- Unusual 11 Mid-Day Movers 11/11: NCST, SMI, MSN, CHLN Higher; TONE, RHIE, CLWR, STV Lower
- Helicos BioSciences (HLCS) Files $50M Shelf Registration
- Helicos BioSciences (HLCS) Announces Filing of 10-Q; Disengages in Sale of Company
- Helicos BioSciences (HLCS) Comments on Q3 Operations
View All Press ReleasesCompany Press Releases on HLCS
- Helicos BioSciences Announces the Sale of a Helicos(R) Genetic Analysis System to the Leiden University Medical Center in the Netherlands
- Helicos BioSciences Provides Strategic Update
- Helicos BioSciences Q3 2009 Operating Highlights and Strategic Update
- Helicos BioSciences Receives $1000 Genome Award
- Helicos Announces System Sale to Correlagen Diagnostics
StreetInsider Reports on HLCS by Category
View All BlogsBlogs on HLCS
- Biotech: Q3 Market Update
- Three Life Science Companies Line Up for IPOs
- Closing Update: Stocks String Together 3 Straight Wins, Commodities Gain
- Sector Performance Summary for August 10-14th
- Closing Bell: Bulls on vacation (BAC, C, CIT, HLCS, MSFT, GOOG)
View All FilingsSEC Filings on HLCS
- Form 8-K HELICOS BIOSCIENCES CORP For: Nov 09
- Form S-3 HELICOS BIOSCIENCES CORP
- Form 10-Q HELICOS BIOSCIENCES CORP For: Sep 30
- Form 8-K HELICOS BIOSCIENCES CORP For: Oct 27
- Form 4 HELICOS BIOSCIENCES CORP For: Oct 15 Filed by: Allison Elisabeth
Comments on recent HLCS articles
Comments on HLCS
No comments are currently available.
on Sep 24, 2009
at 01:47 PM See the Development Pipeline of Interleukin Genetics http://www.ilgenetics.com/content/development-pipeline/index.jsp
Article: Unusual 11 Mid-Day Movers 9/24: BAYN, AM, OSP, HLCS Higher; CHTP, ILI, CNXT, FTBK Lower